Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd). A multicenter observational study NUTRIENTS 2021
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI registry ACTA DIABETOLOGICA 2021
Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study FRONTIERS IN PHARMACOLOGY 2021
Endothelial progenitor cells predict vascular damage progression in naive hypertensive patients according to sex HYPERTENSION RESEARCH 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later. The Era of Vaccines FRONTIERS IN IMMUNOLOGY 2021
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Comparison of Computerized Prescription Support Systems in COVID-19 Patients. INTERCheck and Drug-PIN SN COMPREHENSIVE CLINICAL MEDICINE 2021
Role of vitamin D in cardiovascular diseases ENDOCRINES 2021
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure. randomized trials and beyond HEART FAILURE REVIEWS 2021
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice MOLECULAR METABOLISM 2020
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus. data from an in vivo model NUTRIENTS 2020
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects NUTRIENTS 2020
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival INTERNATIONAL JOURNAL OF ENDOCRINOLOGY 2020
Reduction in global myocardial glucose metabolism in subjects with 1-h postload hyperglycemia and impaired glucose tolerance DIABETES CARE 2020
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice DIABETES, OBESITY AND METABOLISM 2020
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects NUTRIENTS 2020
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2020
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2020

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma